Potential use of olanzapine in treatment of substance dependence disorders.
Sattar
S Pirzada
SP
Grant
Kathleen
K
Bhatia
Subhash
S
Petty
Frederick
F
D000437:Alcoholism / Q000188:drug therapy / Q000523:psychology; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001569:Benzodiazepines; D001714:Bipolar Disorder / Q000150:complications / Q000188:drug therapy; D019970:Cocaine-Related Disorders / Q000150:complications / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D010890:Pirenzepine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D019966:Substance-Related Disorders / Q000188:drug therapy* / Q000523:psychology
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine